Topic: Psoriasis
ZURICH (Reuters) - Novartis said its drug AIN457 helped alleviate the symptoms of people suffering from moderate-to-severe plaque psoriasis, the Swiss firm said on Monday based on the results of a mid-stage study.Plaque psoriasis is a common hereditary, immune-mediated systemic disorder characterized ...
A study of nearly 7,000 people led by a researcher at Indiana University analyzed the relationship between HDL, or good cholesterol, and major coronary events. Exposure to heavy traffic?whether you're traveling by car, bike, or public transit?may double your risk of a ...
This study will evaluate an investigational drug. The research site is in Los Angeles, Calif.. This study will evaluate an investigational drug for chronic low back pain or arthritis. The research site is in Chicago, Ill.. The research site is in Burbank, ...
As if having psoriasis wasn't difficult enough, nearly half of kids with the skin problem have been bullied at least once in the past six months, according to a new survey.. The poll of U.S. parents of children with psoriasis found that ...
Up to 7.5 million people in the U.S. suffer from psoriasis or psoriatic arthritis according to the National Psoriasis Foundation. General symptoms include red skin patches with silver-colored scales, cracked skin, itching or burning, nails with ridges and stiff or swollen joints. ...
Zanolimumab (expected trade name HuMax-CD4 Genmab initiates Phase II Study with HuMax-CD4 ) is a human monoclonal antibody and an immunosuppressive drug . Statement On A Nonproprietary Name Adopted By The USAN Council - Zanolimumab , American Medical Association .
Scalp Psoriasis is a common expression of psoriasis, a non contagious, genetic disease that affects the skin. Psoriasis is caused by the white blood cells, specifically the T lymphocytes, attacking healthy skin cells by mistake. More than 10% of the body affected ...
Ustekinumab (INN , experimental name CNTO 1275 , proprietary commercial name Stelara , In September 2008, Centocor released result of a study comparing etanercept and ustekinumab. with a significant increase in effectiveness. Drug for serious psoriasis tops competition" The Associated Press. Patients ...
If you have red and patchy skin that flakes when it is touched and becomes very itchy then you may find yourself under attack from a common skin complaint known as psoriasis. Psoriasis symptoms will occur when the immune system is not ...
Severe plaque psoriasis, so called because of the large, red plaque-like lesions that appear all over the body, is something that so many people have to deal with. Usually, the first port of call for severe psoriasis is topical therapy. Phototherapy is ...
